Welcome to O2H
 
 
Welcome to O2H
 
O2h now a part of the Piramal group
 
O2h to provide chemistry support to Chromocell.
 

O2h to provide discovery support to Karyopharm Therapeutics

 
Heptares Therapeutics extends Multi-FTE collaboration with O2h
 
MRCT and O2h announce medicinal chemistry collaboraion. 
 
O2h attending Chem Outsourcing Conference
Long Branch NJ, USA, 12-15 September 2011 
 
O2h, part of Piramal CPhi stand
Contact us to arrange a dinner meeting on the 26th of October!
Frankfurt, Germany, 25-27 October 2011 
 
O2h attending BioEurope2011

Get in touch to meet with us! 

31 October - 2 November 2011
Dusseldorf, Germany
 
O2h attending Genesis
London, UK 1 December 2011
 
O2h attending JP Morgan
San Francisco, USA, 9-13 January 2012
 
 
Medicinal Chemistry
O2h has a wide range of expertise in medicinal chemistry to help accelerate the drug discovery process. O2h can provide medicinal chemistry input to hit-to-lead and lead optimisation projects as well as at the pre-clinical developmental stage. Specifically, the O2h team has demonstrated expertise in:
 
Lead Generation
 
Ligand design for pre-defined targets
Synthesis of a homologous or diverse series of compounds for drug discovery projects
Design and generation of libraries of structurally related compounds (close structural analogs, bioisosters etc.)
Combinatorial synthesis of general as well as focused libraries
Quick search for surrogates of core chemical scaffold.
 
Lead Optimization and Structure Activity Relationship (SAR) studies
 
Hit-to-lead and Lead optimization with consideration of prior art, patentability and other IP issues
Computational chemistry and molecular modeling for the design of ligands
Design of virtual library with chemical diversity
Establishing structure-activity relationships
Prioritizing compounds for in-vitro screening
Generation of lead molecules using traditional/iterative medicinal chemistry approach
 
 
     
Sitemap